Fast surface crystallization of amorphous griseofulvin below T g

Pharmaceutical Research

Volumn 27, Issue 8, 2010, Pages 1558-1567

  Zhu, Lei ^a   Jona, Janan ^b   Nagapudi, Karthik ^b   Wu, Tian ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b AMGEN INC   (United States)

Author keywords

amorphous solids; coating; crystallization kinetic; griseofulvin; surface enhanced crystallization

Indexed keywords

GOLD; GRISEOFULVIN; INDOMETACIN; NIFEDIPINE; GLASS; POWDER;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG STABILITY; GLASS TRANSITION TEMPERATURE; MATERIAL COATING; MICROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; ROOM TEMPERATURE; STORAGE TEMPERATURE; SURFACE PROPERTY; TEMPERATURE DEPENDENCE; X RAY POWDER DIFFRACTION; CHEMICAL STRUCTURE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; POWDER; TRANSITION TEMPERATURE; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLOGRAPHY, X-RAY; DRUG STABILITY; GLASS; GOLD; GRISEOFULVIN; MOLECULAR STRUCTURE; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES; TRANSITION TEMPERATURE; X-RAY DIFFRACTION;

EID: 77955469110     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0140-8     Document Type: Article

References (28)

1. L Yu 2001 Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv Drug Deliv Rev 48 27 42 10.1016/S0169-409X(01)00098-9 11325475 (Pubitemid 32454482)
2. M Kennedy J Hu P Gao L Li A Ali-Reynolds B Chal, et al. 2008 Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study Mol Pharm 5 981 93 10.1021/mp800061r 19434920
3. TMS Abu 1999 Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs J Pharm Sci 88 1058 66 10.1021/js980403l (Pubitemid 29480600)
4. Y Guo SR Byrn G Zografi 2000 Physical characteristics and chemical degradation of amorphous quinapril hydrochloride J Pharm Sci 89 128 43 10.1002/(SICI)1520-6017(200001)89:1<128::AID-JPS13>3.0.CO;2-Z 10664545 (Pubitemid 30080161)
5. MD Ediger P Harrowell L Yu 2008 Crystal growth kinetics exhibit a fragility-dependent decoupling from viscosity J Chem Phys 128 034706 9 10.1063/1.2815325
6. BC Hancock SL Shamblin G Zografi 1995 Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures Pharm Res 12 799 806 10.1023/A:1016292416526 7667182
7. BC Hancock G Zograti 1997 Characteristics and significance of the amorphous state in pharmaceutical systems J Pharm Sci 86 1 12 10.1021/js9601896 9002452
8. E Tombari S Presto G Johari R Shanker 2008 Molecular mobility, thermodynamics and stability of Griseofulvin's ultraviscous and glassy states from dynamic heat capacity Pharm Res 25 902 12 10.1007/s11095-007-9444-8 17899326 (Pubitemid 351661839)
9. D Zhou G Geoff D Law DJW Grant EA Schmitt 2008 Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin Mol Pharm 5 927 36 10.1021/mp800169g 19434849
10. T Wu L Yu 2006 Surface crystallization of indomethacin below Tg Pharm Res 23 2350 5 10.1007/s11095-006-9023-4 16927184 Epub 2006 Aug 2323 (Pubitemid 44511514)
11. L Zhu L Wong L Yu 2008 Surface-enhanced crystallization of amorphous nifedipine Mol Pharm 5 921 6 10.1021/mp8000638 19434917
12. S Yamamura R Takahira Y Momose 2007 Crystallization kinetics of amorphous griseofulvin by pattern fitting procedure using X-ray diffraction data Pharm Res 24 880 7 10.1007/s11095-006-9204-1 17372690 (Pubitemid 46675388)
13. T Wu L Yu 2006 Origin of enhanced crystal growth kinetics near Tg probed with indomethacin polymorphs J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 110 15694 9 16898713
14. T Matsumo DC Bogue 1977 Stress birefringence in amorphous polymers under nonisothermal conditions J Polym Sci Polym Phys Ed 15 1663 74 10.1002/pol.1977.180150914
15. T Wu M de Villiers L Yu 2007 Inhibiting surface crystallization of amorphous indomethacin by nanocoating Langmuir 23 5148 53 10.1021/la070050i 17397203 (Pubitemid 46732007)
16. g without and with polyvinylpyrrolidone J Pharm Sci 96 1131 8 10.1002/jps.20925 17455342 (Pubitemid 46797481)
17. L Yu SM Reutzel-Edens CA Mitchell 2000 Crystallization and polymorphism of conformationally flexible molecules: problems, patterns, and strategies Org Process Res Dev 4 396 402 10.1021/op000028v
18. Swallen S, Kearns K, Mapes M, Kim Y, McMahon R, Ediger M, et al. Organic glasses with exceptional thermodynamic and kinetic stability. Science. 2007;315:353-6.
19. Z Fakhraai JA Forrest 2008 Measuring the surface dynamics of glassy polymers Science 319 600 4 10.1126/science.1151205 18239120 (Pubitemid 351197058)
20. Y Sun H Xi S Chen MD Ediger L Yu 2008 Crystallization near glass transition: transition from diffusion-controlled to diffusionless crystal growth studied with seven polymorphs J Phys Chem B 112 5594 601 10.1021/jp7120577 18407712 (Pubitemid 351704577)
21. Y Sun H Xi MD Ediger R Richert L Yu 2009 Diffusion-controlled and "diffusionless" crystal growth near the glass transition temperature: relation between liquid dynamics and growth kinetics of seven ROY polymorphs J Chem Phys 131 074506 9 10.1063/1.3200228 19708750
22. H Xi Y Sun L Yu 2009 Diffusion-controlled and diffusionless crystal growth in liquid o-terphenyl near its glass transition temperature J Chem Phys 130 094508 9 10.1063/1.3081047 19275410
23. M Savolainen A Heinz C Strachan KC Gordon J Yliruusi T Rades, et al. 2007 Screening for differences in the amorphous state of indomethacin using multivariate visualization Eur J Pharm Sci 30 113 23 10.1016/j.ejps.2006.10.010 17169536 (Pubitemid 46149278)
24. D Luo BD Anderson 2008 Application of a two-state kinetic model to the heterogeneous kinetics of reaction between cysteine and hydrogen peroxide in amorphous lyophiles J Pharm Sci 97 3907 26 10.1002/jps.21257 18200535
25. KJ Dawson KL Kearns MD Ediger MJ Sacchetti GD Zografi 2009 Highly stable indomethacin glasses resist uptake of water vapor J Phys Chem B 113 2422 7 10.1021/jp808838t 19183039
26. A Forster J Hempenstall I Tucker T Rades 2001 The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion Drug Dev Ind Pharm 27 549 60 10.1081/DDC-100105180 11548862 (Pubitemid 32803574)
27. M Yoshioka BC Hancock G Zografi 1994 Crystallization of indomethacin from the amorphous state below and above its glass transition temperature J Pharm Sci 83 1700 5 10.1002/jps.2600831211 7891297
28. C Bhugra R Shmeis S Krill M Pikal 2006 Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition Pharm Res 23 2277 90 10.1007/s11095-006-9079-1 16933094 (Pubitemid 44511509)